Literature DB >> 19251010

Midazolam with meperidine or fentanyl for colonoscopy: results of a randomized trial.

Bu'Hussain Hayee1, Jason Dunn, Aathavan Loganayagam, Mandy Wong, Vishal Saxena, David Rowbotham, Alistair McNair.   

Abstract

BACKGROUND: A combination of midazolam and opioid is usually used to achieve sedation and analgesia during colonoscopy. Two commonly used opioids are meperidine and fentanyl, but few studies have compared their efficacy.
OBJECTIVE: This randomized trial aimed to compare the efficacy and recovery time of 2 sedation regimens consisting of midazolam in combination with either meperidine or fentanyl. DESIGN, SETTING, AND PATIENTS: A total of 300 consecutive, unselected adults attending outpatient colonoscopy at a District General Hospital were enrolled with informed consent and randomized to receive midazolam with meperidine or fentanyl. Data for procedure times, perceived discomfort (according to standard 100-mm visual analog scales [VAS]), and recovery time were collected. Patients and all endoscopy staff directly involved with the procedure were blinded to the regimen used. MAIN OUTCOME MEASUREMENTS: Primary: patients' experience of pain (postrecovery VAS score); secondary: recovery time.
RESULTS: A total of 287 patients (150 female, mean [SD] age 54 [17] years) were studied. Recovery time (in minutes) was significantly shorter in patients receiving fentanyl (n = 138) than in those receiving meperidine (n = 149, mean +/- SE: 13.7 +/- 1.8 vs 18.7 +/- 1.7, P = .03), whereas there was no difference in the patients', endoscopists', or nurses' perception of pain during the procedure between the 2 groups. Both groups received a median dose of 3 mg of midazolam (range 2-5 mg). In patients receiving lower doses (2-2.5 and 3-3.5 mg), recovery times were significantly faster with fentanyl (P < .01 and <.05, respectively), whereas at higher doses of midazolam (> or =4 mg) there was no difference between the 2 groups. LIMITATIONS: The use of VAS scores and nurse assessment of recovery time were chosen in this study because, despite their subjectivity, these measures were felt to most closely reflect true clinical practice.
CONCLUSIONS: The use of fentanyl in combination with low-dose midazolam results in significantly faster recovery from sedation compared with meperidine, without any apparent loss of analgesic effect.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19251010     DOI: 10.1016/j.gie.2008.09.033

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  15 in total

1.  The impact of advances in instrumentation and techniques of colonoscopy from 1988 to 2008 on inpatient colonoscopy performance at a high volume endoscopy unit in the United States: significantly shorter procedure time, higher completion rate, performance on sicker inpatients, and near disappearance of flexible sigmoidoscopy.

Authors:  Mitchell S Cappell; Rami Abboud
Journal:  Dig Dis Sci       Date:  2010-04-17       Impact factor: 3.199

2.  Review on sedation for gastrointestinal tract endoscopy in children by non-anesthesiologists.

Authors:  Rok Orel; Jernej Brecelj; Jorge Amil Dias; Claudio Romano; Fernanda Barros; Mike Thomson; Yvan Vandenplas
Journal:  World J Gastrointest Endosc       Date:  2015-07-25

3.  Effect of carbamazepine or phenytoin therapy on blood level of intravenously administered midazolam: a prospective cohort study.

Authors:  Tomoko Hayashi; Hitoshi Higuchi; Yumiko Tomoyasu; Minako Ishii-Maruhama; Shigeru Maeda; Takuya Miyawaki
Journal:  J Anesth       Date:  2015-08-14       Impact factor: 2.078

4.  Anesthesiologist involvement in screening colonoscopy: temporal trends and cost implications in the medicare population.

Authors:  Vijay S Khiani; Pamela Soulos; John Gancayco; Cary P Gross
Journal:  Clin Gastroenterol Hepatol       Date:  2011-07-23       Impact factor: 11.382

5.  Safety and efficacy of fentanyl versus pethidine in cataract surgery under propofol- based sedation: A double-blind randomized controlled clinical trial.

Authors:  Hamidreza Shetabi; Seyed Jalal Hashemi; Fariba Haghi; Dariush Moradi Farsani
Journal:  J Res Med Sci       Date:  2020-08-24       Impact factor: 1.852

Review 6.  Sedation in gastrointestinal endoscopy: current issues.

Authors:  John K Triantafillidis; Emmanuel Merikas; Dimitrios Nikolakis; Apostolos E Papalois
Journal:  World J Gastroenterol       Date:  2013-01-28       Impact factor: 5.742

7.  Assessing the stability and safety of procedure during endoscopic submucosal dissection according to sedation methods: a randomized trial.

Authors:  Chan Hyuk Park; Seokyung Shin; Sang Kil Lee; Hyuk Lee; Yong Chan Lee; Jun Chul Park; Young Chul Yoo
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

8.  The Benefit of Fentanyl in Effective Sedation and Quality of Upper Endoscopy: A Double-Blinded Randomized Trial of Fentanyl Added to Midazolam Versus Midazolam Alone for Sedation.

Authors:  Khurram J Khan; Houssein Fergani; Subhas C Ganguli; Subash Jalali; Robert Spaziani; Keith Tsoi; David G Morgan
Journal:  J Can Assoc Gastroenterol       Date:  2018-08-09

9.  Comparison between the recovery time of alfentanil and fentanyl in balanced propofol sedation for gastrointestinal and colonoscopy: a prospective, randomized study.

Authors:  Wai-Meng Ho; Chia-Ming Yen; Chin-Hung Lan; Chung-Yi Lin; Su-Boon Yong; Kai-Lin Hwang; Ming-Chih Chou
Journal:  BMC Gastroenterol       Date:  2012-11-21       Impact factor: 3.067

10.  Portable inhaled methoxyflurane is feasible and safe for colonoscopy in subjects with morbid obesity and/or obstructive sleep apnea.

Authors:  Nam Q Nguyen; Leanne Toscano; Matthew Lawrence; Vinh-An Phan; Rajvinder Singh; Peter Bampton; Robert J Fraser; Richard H Holloway; Mark N Schoeman
Journal:  Endosc Int Open       Date:  2015-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.